Neurostimulation Devices Market to Reach $13.5 Billion by 2032

The neurostimulation devices market is entering a scale-up phase as clinical outcomes, product innovation, and reimbursement alignment converge. Hospitals, payers, and manufacturers are leveraging improved efficacy and broader indications to accelerate replacement of legacy systems and expand access for complex neurological and pain conditions.